|
Lipids
Citations 271-280 of 397 total displayed.
|
Past content
(since Feb 1999):
|
- Correspondence
Primary Prevention Lipid-Lowering Drug Therapy • Response
- Donald O. Fedder, Carol E. Koro, Gilbert J. L’Italien, Antonio M. Gotto, Jr, and Lewis H. Kuller
Circulation 2002;106:e35-36e, doi:10.1161/01.CIR.0000025828.88749.55
[Full text]
- Clinical Cardiology: New Frontiers
Lessons Learned From Recent Cardiovascular Clinical Trials: Part II
- David L. DeMets and Robert M. Califf
Circulation 2002;106:880-886, doi:10.1161/01.CIR.0000023220.26465.89
[Full text]
- Articles
Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery Calcification. A Prospective Evaluation
- Stephan Achenbach, Dieter Ropers, Karsten Pohle, Alexander Leber, Christian Thilo, Andreas Knez, Theresa Menendez, Ralph Maeffert, Magda Kusus, Matthias Regenfus, Andrea Bickel, Ralph Haberl, Gerhard Steinbeck, Werner Moshage, and Werner G. Daniel
Circulation published August 5, 2002, doi:10.1161/01.CIR.0000027567.49283.FF
[Abstract]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part II
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:626-630, doi:10.1161/01.CIR.0000021408.40925.63
[Full text]
- Clinical Cardiology: New Frontiers
Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
- Daniel B. Mark and Mark A. Hlatky
Circulation 2002;106:516-520, doi:10.1161/01.CIR.0000021407.93752.7B
[Full text]
- Clinician Update
Metabolic Syndrome: Pathophysiology and Implications for Management of Cardiovascular Disease
- Gerald Reaven
Circulation 2002;106:286-288, doi:10.1161/01.CIR.0000019884.36724.D9
[Full text]
- AHA Scientific Statements
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases
- Thomas A. Pearson, Steven N. Blair, Stephen R. Daniels, Robert H. Eckel, Joan M. Fair, Stephen P. Fortmann, Barry A. Franklin, Larry B. Goldstein, Philip Greenland, Scott M. Grundy, Yuling Hong, Nancy Houston Miller, Ronald M. Lauer, Ira S. Ockene, Ralph L. Sacco, James F. Sallis, Jr, Sidney C. Smith, Jr, Neil J. Stone, and Kathryn A. Taubert
Circulation 2002;106:388-391, doi:10.1161/01.CIR.0000020190.45892.75
[Full text]
- Correspondence
Low High-Density Lipoprotein Cholesterol and Response to Simvastatin Therapy in Scandinavian Simvastatin Survival Study (4S) • Response
- Sander Robins, Christie M. Ballantyne, Anders G. Olsson, Thomas J. Cook, Michele F. Mercuri, Terje R. Pedersen, and John Kjekshus
Circulation 2002;106:e8, doi:10.1161/01.CIR.0000019970.99823.B2
[Full text]
- Images in Cardiovascular Medicine
Specific Cardiomyopathy Caused by Multisystemic Lipid Storage in Jordan’s Anomaly
- Yuichi Oshima, Hisao Hirota, Hiroyuki Nagai, Masahiro Izumi, Yoshikazu Nakaoka, Tomoaki Osugi, Yasushi Fujio, Hitone Tateyama, Masanori Kikui, Keiko Yamauchi-Takihara, and Ichiro Kawase
Circulation 2002;106:280-281, doi:10.1161/01.CIR.0000018080.37316.D6
[Full text]
- Clinical Investigations and Reports
Different Metabolic Predictors of White-Coat and Sustained Hypertension Over a 20-Year Follow-Up Period: A Population-Based Study of Elderly Men
- Kristina Björklund, Lars Lind, Bengt Vessby, Bertil Andrén, and Hans Lithell
Circulation 2002;106:63-68; published online before print as doi:10.1161/01.CIR.0000019737.87850.5A
[Abstract]
[Full text]
|
|
